Cancer Institute Clinical Trials - Miscellaneous

Solid Tumor

#130337  
Title:  Phase I, Open-Label, Crossover, Randomized, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Administered to Cancer Patients
Study Location: Temple Main Campus

For more information or to enroll in a study, please call 254-724-5407.


Print
Text Size
A
A
A